Page last updated: 2024-08-24

acridine orange and Leukemia

acridine orange has been researched along with Leukemia in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-199010 (83.33)18.7374
1990's1 (8.33)18.2507
2000's1 (8.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bezerra, DP; Câmara, CA; Cavalcanti, BC; Costa-Lotufo, LV; Lima, MA; Magalhães, HI; Moraes, MO; Pessoa, C; Rao, VS; Silveira, ER1
ALTERA, KP; BIJLENGA, G; COHEN, D; FERRIGAN, L1
HIRAKI, K; KOTSUKA, T1
BRAUNSTEINER, H; PAKESCH, F1
Derulska, D; Kendziorek, A; Krawczyński, J; Mdzewski, B; Rokicka, R; Romer, B; Tomaszewska, Z1
Tattersall, MH; Taylor, IW1
Darzynkiewicz, Z; Hotz, MA; Traganos, F1
Johnson, DA; Keating, MJ; Maddox, AM1
Walle, AJ1
Boldog, F; Kopper, L; Lapis, K; Timar, J1
Böhmer, RM1
Barlogie, B; Freireich, EJ; Johnston, DA; Keating, M; Maddox, AM; Youness, E1

Other Studies

12 other study(ies) available for acridine orange and Leukemia

ArticleYear
Kauren-19-oic acid induces DNA damage followed by apoptosis in human leukemia cells.
    Journal of applied toxicology : JAT, 2009, Volume: 29, Issue:7

    Topics: Acridine Orange; Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Comet Assay; Diterpenes; DNA Damage; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ethidium; Fluorescent Dyes; Glioblastoma; HL-60 Cells; Humans; Inhibitory Concentration 50; Intercalating Agents; K562 Cells; Leukemia; Melanoma; Molecular Structure; Necrosis

2009
The use of acridine orange fluorescent staining of peripheral blood cells as a rapid method for the detection of abnormal proliferation of haematopoietic tissues.
    Bulletin of the World Health Organization, 1962, Volume: 26

    Topics: Acridine Orange; Acridines; Blood Cells; Fluorescent Dyes; Hematopoietic System; Humans; Leukemia; Neoplasms; Staining and Labeling

1962
[SYMPOSIUM ON THE CLASSIFICATION OF LEUKEMIA. 5. CLASSIFICATION UNDER THE FLUORESCENCE MICROSCOPE (USING ACRIDINE ORANGE)].
    Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society, 1963, Volume: 26

    Topics: Acridine Orange; Acridines; Classification; Fluorescence; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Microscopy; Microscopy, Fluorescence

1963
[Differentiation of myeloid and lymphatic cells in fluorescence microscopy; vital staining with acridine orange].
    Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete, 1951, Volume: 32, Issue:7

    Topics: Acridine Orange; Coloring Agents; Humans; Leukemia; Microscopy, Fluorescence; Staining and Labeling

1951
The distribution of euchrysine-binding grains of the peripheral and bone marrow stem cells in different types of acute leukemia.
    Archivum immunologiae et therapiae experimentalis, 1984, Volume: 32, Issue:6

    Topics: Acridine Orange; Acute Disease; Adolescent; Aminoacridines; Bone Marrow; Child; Child, Preschool; Hematopoietic Stem Cells; Histocytochemistry; Humans; Infant; Leukemia; Staining and Labeling

1984
Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry.
    Cancer research, 1981, Volume: 41, Issue:4

    Topics: Acridine Orange; Cells, Cultured; Cytological Techniques; DNA; Dose-Response Relationship, Drug; Fluorescence; Humans; Hypoxanthines; Interphase; Leukemia; Methotrexate; RNA; Thymidine

1981
Changes in nuclear chromatin related to apoptosis or necrosis induced by the DNA topoisomerase II inhibitor fostriecin in MOLT-4 and HL-60 cells are revealed by altered DNA sensitivity to denaturation.
    Experimental cell research, 1992, Volume: 201, Issue:1

    Topics: Acridine Orange; Alkenes; Cell Death; Cell Line; Cell Nucleus; Chromatin; G2 Phase; Humans; Leukemia; Polyenes; Pyrones; S Phase; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1992
5-bromodeoxyuridine (BUdR) quenching of acridine orange fluorescence distinguishes cycling and non-cycling normal and malignant bone marrow cells in vitro.
    Leukemia research, 1989, Volume: 13, Issue:9

    Topics: Acridine Orange; Bone Marrow; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Humans; In Vitro Techniques; Leukemia; Multiple Myeloma; RNA, Neoplasm; Spectrometry, Fluorescence

1989
Identification of L3 leukemia and Burkitt's lymphoma cells by flow cytometric quantitation of nuclear and cellular RNA and DNA content.
    Leukemia research, 1986, Volume: 10, Issue:3

    Topics: Acridine Orange; Burkitt Lymphoma; Cell Cycle; Cell Nucleus; DNA, Neoplasm; Flow Cytometry; Humans; Leukemia; RNA, Neoplasm

1986
Flow cytometric measurements and electron microscopy of cell surface glycosaminoglycans using acridine orange.
    The Histochemical journal, 1985, Volume: 17, Issue:1

    Topics: Acridine Orange; Animals; Ascitic Fluid; Cell Membrane; Flow Cytometry; Glycosaminoglycans; Humans; In Vitro Techniques; Leukemia; Mice; Mice, Inbred C57BL

1985
Flow cytometric detection of a two-step cell death induced by hyperthermia.
    Cytometry, 1985, Volume: 6, Issue:3

    Topics: Acridine Orange; Cell Line; Cell Survival; Ethidium; Flow Cytometry; Hot Temperature; Humans; Kinetics; Leukemia

1985
DNA-RNA measurements in patients with acute leukemia undergoing remission induction therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:6

    Topics: Acridine Orange; Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Cycle; DNA, Neoplasm; Histocytochemistry; Humans; Interphase; Leukemia; Prognosis; Recurrence; RNA, Neoplasm

1985